Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Kalaris Therapeutics Inc. (KLRS) had Weighted-Average Shares Outstanding (Diluted) of 18.70M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-11.35M |
|
-- |
|
-- |
|
$12.26M |
|
$-12.26M |
|
$0.91M |
|
$-11.35M |
|
$-11.35M |
|
$-11.35M |
|
$-11.35M |
|
$-11.35M |
|
$-11.35M |
|
$-12.26M |
|
$-12.26M |
|
18.70M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
18.70M |
$-0.61 |
|
$-0.61 |
|
| Balance Sheet Financials | |
$91.65M |
|
-- |
|
$1.19M |
|
$92.84M |
|
$7.65M |
|
-- |
|
$32.08M |
|
$39.73M |
|
$53.12M |
|
$53.12M |
|
$53.12M |
|
18.70M |
|
| Cash Flow Statement Financials | |
$-19.98M |
|
-- |
|
$107.27M |
|
$1.64M |
|
$88.93M |
|
$87.29M |
|
$0.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.37% |
|
-21.37% |
|
-12.23% |
|
-21.37% |
|
$2.84 |
|
$-1.07 |
|
$-1.07 |
|